Market+ (iPhone)

Market+ (Android)

US STOCKS

FUNDS

FX & CRYPTO

SH/SZ-HK

HK STOCKS

IPO Plus - IPO

To-be Listed

	Name▼ / Code▼	Industry	Offer Price	Lot Size	Entry Fee	Closing Date	Grey Market Date▼	Listing Date▲
	REFIRE 02570.HK	Electrical Components & Equipment	145-165	20	3,333	2024/12/03	2024/12/05	2024/12/06
	Dmall 02586.HK	Application Software	30.21	100	N/A	2024/12/03	2024/12/05	2024/12/06

Summary

We are the largest provider in the Integrated Healthcare Marketing Solutions Market, which primarily include medical conference services, patient education and screening services and marketing strategy and consulting services, for cardio-cerebral-vascular diseases, or CCVDs, in China in terms of revenue in 2019, with a market share of 4.9% in the highly fragmented integrated healthcare marketing solutions industry for CCVDs, according to the CIC Report. The Integrated Healthcare Marketing Solutions Market for CCVDs in China was a RMB5.6 billion market in 2019, accounting for approximately 10.6% of the overall Integrated Healthcare Marketing Solutions Market in China. Founded in 2000, we primarily provide (i) medical conference services, (ii) patient education and screening services, and (iii) marketing strategy and consulting services with the goal to address the unmet needs of each key constituent of the CCVD healthcare ecosystem, including physicians, patients, pharmaceutical companies, medical non-governmental organizations, or NGOs, and hospitals, and to bridge the gaps among these constituents. In addition to providing integrated healthcare marketing solutions, we also began to offer CRO services in late 2019 which primarily consist of patients' recruitment and clinical data collection services, and internet hospital services which mainly provide online follow up consultation to the physicians' existing patients and e-prescription service. We focus on CCVDs though our disease coverage has been extended to other chronic diseases, such as diabetes and respiratory diseases. We have been committed to enabling better medical service and patient experience, improved disease control and lower the burden on the healthcare system in the long run through our services. We benefit from a high quality base of well-known customers and a physicians network, which have been crucial to our historical success. We have collaborated with some of China's most esteemed medical NGOs, including the only medical association for CCVDs recognized by the China Association for Science and Technology (中國科學技術協會), or CAST, which is the official organization for national professional societies in relation to science and technology in China. According to the CIC Report, among the global top ten pharmaceutical companies in terms of revenue in 2019, five were our customers during the Track Record Period. Moreover, we have developed a network of approximately 24,000 CCVD physicians as of June 30, 2020, among which over 70% worked for Grade 3 hospitals in China. All these physicians have participated in our provision of integrated healthcare marketing solutions. We have also established a medical advisory panel comprising four influential and well-recognized CCVD physicians to advise us on our strategic direction and business expansion, including the development of internet hospital services and CRO services. We have built various technology platforms to enhance our integrated healthcare marketing solutions. To strengthen our conference management capabilities, we have launched the Conference+ App (醫會+) for users, i.e. medical NGOs and pharmaceutical companies, to submit onsite conference requests and monitor conference implementation. We have also acquired Weiliandong, the owner of the Giraffe Platform which is a video conferencing and online education tool that enables hospitals to host or attend online medical conferences and access training videos recorded by physicians. To boost our patient education and screening capabilities, we developed and launched the Online Conference Assistant (線上會議助手), a WeChat mini-program that assists physicians in organizing and managing onsite patient education classes, as well as various WeChat public accounts where patients can find self-management support through watching educational videos, reading disease-related educational articles and conducting disease risk screening. We developed a mobile platform which offers online consultation and e-prescription services under our internet hospital segment as of the Latest Practicable Date. Source: Mediwelcome (02159) Prospectus (IPO Date : 2020/12/31)
Listing Market	MAIN
Industry	Health Care Services
Background	Others
Major Business Area	N/A

Corporate Information

Substantial Shareholders	Shi Wei (21.63%) Yang Weimin (12.71%) Zhang Yitao (12.71%) The Core Trust Company Limited (10.00%) Wang Liang (7.22%)
Directors	Shi Wei (Chairman and Executive Director) Yang Weimin (Vice Chairman and Executive Director) Wang Liang (Chief Executive Officer and Executive Director) Liu Guijin (Executive Director) Liu Xia (Non-Executive Director) David Zheng Wang (Independent Non-Executive Director) Song Ruilin (Independent Non-Executive Director) Yang Xiaoxi (Independent Non-Executive Director)
Company Secretary	Zhao Luyang Tsoi Siu Wai
Principal Bankers	Bank of Communications Co., Ltd.
Solicitors	Sidley Austin
Auditors	Moore CPA Limited
Registered Office	Unit 1218, 12/F., Corporation Square, No.8 Lam Lok Street, Kowloon Bay, Kowloon, Hong Kong
Share Registrars	Computershare Hong Kong Investor Services Ltd. [Tel: (852) 2862-8628]
Share Registrars Tel No	(852) 2862-8628
Internet Address	http://www.mediwelcome.com
Email Address	[email protected]
Tel No	(852) 2725-0298
Fax No	(852) 2802-0331

SITEMAP

AASTOCKS.com

Members

Forgot Password

About Us

Email: [email protected]

AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved.

Disclaimer

You expressly agree that the use of this app/website is at your sole risk.

AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd, Nasdaq, Inc., their respective holding companies and/or any subsidiaries of such holding companies, their Sources and/or other third party data provider(s) endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co.Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) make any express or implied offers, representations or warranties (including, without limitation, any warranty or merchantability or fitness for a particular purpose or use) regarding the Information.

Neither AASTOCKS.com Limited, HKEx Information Services Limited, China Investment Information Services Limited, Shenzhen Securities Information Co. Ltd., Nasdaq, Inc. nor their respective holding companies and/or any subsidiaries of such holding companies nor their Sources and/or other third party data provider(s) will be liable to any Subscriber or any other party for any interruption, inaccuracy, error, or omission, regardless of cause, in the Information or for any damages (whether direct or indirect, consequential, punitive, or exemplary) resulting from its use by any party.

AASTOCKS.com Limited shall not be liable for any failure or delay in performance of its obligations under this Disclaimer because of circumstances beyond its reasonable control, including but without limitation, acts of God, typhoons, rainstorms, other natural disasters, government restrictions, strikes, wars, virus outbreak, network failures or telecommunications failures.

Morningstar Disclaimer: Copyright © 2020 Morningstar, Inc. All Rights Reserved. The information, data, analyses and opinions ("Information") contained herein: (1) include the proprietary information of Morningstar and Morningstar’s third party licensors; (2) may not be copied or redistributed except as specifically authorised; (3) do not constitute investment advice; (4) are provided solely for informational purposes; and (5) are not warranted to be complete, accurate or timely. Morningstar is not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

The information and contents contained in this app/website are based on the analyses and interpretations of publicly available information obtained from sources believed to be reliable. Such analyses and information have not been independently verified and AASTOCKS.com Limited makes no guarantees to their accuracy, completeness, timeliness or correctness.

The information, financial market data, quotes, charts, statistics, exchange rate, news, research, analysis, buy and sell ratings, Education Center and other information on this app/website should be used as references only at your own discretion. Prior to the execution of a security or any other trade based upon the Information, you are advised to consult independent professional advice to verify pricing information or to obtain more detailed market information. AASTOCKS.com Limited is not soliciting any subscriber or app/website visitor to execute any trade. Any trades executed following the said information, commentaries and/or buy/sell ratings on this app/website are taken at your own risk for your own account.

AASTOCKS.com Limited provides the information and services on an "AS IS" basis. The information and contents on this app/website are subject to change without notice. AASTOCKS.com Limited reserves the right, in its sole discretion but without any obligation, to make improvements to, or correct any error or omissions in any portion of this app/website at any time.

The subscriber or app/website visitor agrees not to reproduce, retransmit, disseminate, distribute, broadcast, publish, circulate, sell or commercially exploit the information and contents on this app/website in any manner without the express written consent of AASTOCKS.com Limited.

Investment involves risk. You may make use of the Education Center of this website for academic reference purposes at your own discretion. AASTOCKS.com Limited cannot and does not give any assurance that the present or future buy/sell commentaries and signals on this app/website will be profitable. AASTOCKS.com Limited cannot guarantee, and the subscriber or app/website visitor should not assume, that the future performance will equal past performance.

AASTOCKS.com Limited may point to other sites that may be of interest to the subscriber or app/website visitor but for which AASTOCKS.com Limited has no responsibility and only provides this as a service to the subscriber or app/website visitor.

AASTOCKS.com Limited does not represent or endorse the accuracy or reliability of any information, advertisements or contents contained on, distributed through, or linked, downloaded or accessed from any of the services on this app/website. AASTOCKS.com Limited cannot and does not guarantee the quality or reliability of any products or information purchased or obtained by you as a result of an advertisement or any other information displayed on this app/website.

AATV is a video platform owned by AASTOCKS.com Limited.

You acknowledge that: (i) AATV is provided for information purposes only and, in particular, is not intended for trading purposes; (ii) AATV does not and none of the information contained in its program constitutes a solicitation, offer, opinion, or recommendation by us to buy or sell any security, or to provide legal, tax, accounting, or investment advice or services whether or not regarding the profitability or suitability of any security or investment; and (iii) AATV is not intended for use by, or distribution to, any person or entity in any jurisdiction or country where such use or distribution would be contrary to law or regulation.

The financial analysis or opinion expressed in the AATV programs is for reference and discussion only, and does not represent AASTOCKS.com Limited. Investors must make their own investment decisions based on their own investment objectives and financial situation. AASTOCKS.com Limited shall not, directly or indirectly, be liable, in any way, to you or any other person for any: (i) inaccuracies or errors in or omissions from AATV including, but not limited to, quotes and financial data; (ii) delays, errors, or interruptions in the transmission or delivery of AATV; or (iii) loss or damage arising therefrom or occasioned thereby, or by any reason of nonperformance.

AASTOCKS.com Limited reserves the right to change this Disclaimer at any time by posting changes online at this app/website. You are responsible for reviewing regularly information posted therein to obtain timely notice of such changes. Your continued use of this app / website after changes are posted constitutes your acceptance of this Agreement as modified by the posted changes.

The disclaimer herein shall be governed by the law of the Hong Kong Special Administrative Region of the People's Republic of China ("Hong Kong") and you agree to submit to the exclusive jurisdiction of the Hong Kong courts.

In the event of any discrepancy between the Chinese and English versions, the English version shall prevail.

Last updated on 6 January 2023.